<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>280(2)</volume><submitter>Sperry JL</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the feasibility, efficacy, and safety of early cold stored platelet transfusion compared with standard care resuscitation in patients with hemorrhagic shock.&lt;h4>Background&lt;/h4>Data demonstrating the safety and efficacy of early cold stored platelet transfusion are lacking following severe injury.&lt;h4>Methods&lt;/h4>A phase 2, multicenter, randomized, open label, clinical trial was performed at 5 US trauma centers. Injured patients at risk of large volume blood transfusion and the need for hemorrhage control procedures were enrolled and randomized. The intervention was the early transfusion of a single apheresis cold stored platelet unit, stored for up to 14 days versus standard care resuscitation. The primary outcome was feasibility and the principal clinical out</pubmed_abstract><journal>Annals of surgery</journal><pagination>212-221</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11224567</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Early Cold Stored Platelet Transfusion Following Severe Injury: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC11224567</pmcid><pubmed_authors>Inaba K</pubmed_authors><pubmed_authors>Mallett-Smith S</pubmed_authors><pubmed_authors>Cotton BA</pubmed_authors><pubmed_authors>Doherty JE</pubmed_authors><pubmed_authors>Spinella PC</pubmed_authors><pubmed_authors>Love ET</pubmed_authors><pubmed_authors>Wisniewski SR</pubmed_authors><pubmed_authors>Harner AM</pubmed_authors><pubmed_authors>Hoffman MK</pubmed_authors><pubmed_authors>Sperry JL</pubmed_authors><pubmed_authors>Kornblith LZ</pubmed_authors><pubmed_authors>Leeper CM</pubmed_authors><pubmed_authors>Rosario-Rivera BL</pubmed_authors><pubmed_authors>Kutcher ME</pubmed_authors><pubmed_authors>Yazer MH</pubmed_authors><pubmed_authors>Guyette FX</pubmed_authors><pubmed_authors>Bai Y</pubmed_authors><pubmed_authors>Vincent LE</pubmed_authors><pubmed_authors>Wilson CT</pubmed_authors><pubmed_authors>Cuschieri J</pubmed_authors><pubmed_authors>Kornblith AE</pubmed_authors><pubmed_authors>Seger CP</pubmed_authors><pubmed_authors>Cold Stored Platelet for Hemorrhagic Shock (CRISP-HS) Study Group</pubmed_authors><pubmed_authors>Fox EE</pubmed_authors><pubmed_authors>Zadorozny EV</pubmed_authors><pubmed_authors>Neal MD</pubmed_authors><pubmed_authors>Hudgins J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early Cold Stored Platelet Transfusion Following Severe Injury: A Randomized Clinical Trial.</name><description>&lt;h4>Objective&lt;/h4>To determine the feasibility, efficacy, and safety of early cold stored platelet transfusion compared with standard care resuscitation in patients with hemorrhagic shock.&lt;h4>Background&lt;/h4>Data demonstrating the safety and efficacy of early cold stored platelet transfusion are lacking following severe injury.&lt;h4>Methods&lt;/h4>A phase 2, multicenter, randomized, open label, clinical trial was performed at 5 US trauma centers. Injured patients at risk of large volume blood transfusion and the need for hemorrhage control procedures were enrolled and randomized. The intervention was the early transfusion of a single apheresis cold stored platelet unit, stored for up to 14 days versus standard care resuscitation. The primary outcome was feasibility and the principal clinical out</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-08T06:50:13.836Z</modification><creation>2026-06-08T03:14:31.793Z</creation></dates><accession>S-EPMC11224567</accession><cross_references><pubmed>38708880</pubmed><doi>10.1097/SLA.0000000000006317</doi></cross_references></HashMap>